These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11981460)

  • 21. [Eradication of Helicobacter pylori by triple therapy in ulcerous patients: the role of endoscopy and antibiotic sensitivity].
    Garrido A; Lepe JA; Guerrero FJ; Palomo S
    Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):471-3. PubMed ID: 9918994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
    Hoshiya S; Watanabe K; Tokunaga K; Tanaka A; Ninomiya H; Shingaki M; Itoh T; Saito S; Ishida H; Takahashi S
    J Gastroenterol; 2000; 35(1):10-4. PubMed ID: 10632534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
    Takimoto T; Kimura K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Ido K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S63-6. PubMed ID: 8574739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
    Uthaisaengsook W
    J Med Assoc Thai; 2003 Jul; 86(7):599-602. PubMed ID: 12948252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC; Lu SN; Changchien CS
    Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y; Fukuda Y; Tsujiai T; Tamura K; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():75-6. PubMed ID: 8959526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease.
    Kullavanijaya P; Gonlachanvit S; Mahachai V; Kladchareon N
    J Med Assoc Thai; 2000 Mar; 83(3):230-5. PubMed ID: 10808676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
    Bhatia V; Ahuja V; Das B; Bal C; Sharma MP
    J Gastroenterol Hepatol; 2004 Jun; 19(6):619-25. PubMed ID: 15151614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
    De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
    Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain].
    Gomollón F; Santolaria S; Ducóns JA; Guirao R; Vera J; Montoro M
    Gastroenterol Hepatol; 2000 Feb; 23(2):62-5. PubMed ID: 10726384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience.
    Deltenre M; Jonas C; Otero J; Cozzoli A; Denis P; Burette A; de Koster E
    J Physiol Pharmacol; 1996 Mar; 47(1):59-69. PubMed ID: 8777308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.
    Cardenas VM; Graham DY; El-Zimaity HM; Opekun AR; Campos A; Chavez A; Guerrero L
    Aliment Pharmacol Ther; 2006 Jan; 23(2):295-301. PubMed ID: 16393310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.